Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

Ga-Young Song, Seok Jin Kim, MD PhD, Sang Eun Yoon, Jin Seok Kim, MD PhD, Ho-Young Yhim, MD PhD, Youngil Koh, MD PhD, Sung Yong Oh, MD PhD, Ho Sup Lee, MD PhD, Ho-Jin Shin, MD PhD, Young Rok Do, MD PhD, Won Sik Lee, MD PhD, Lee Gyeong-Won, Dae Sik Kim, Yong Park, Deok-Hwan Yang, MD PhD

Blood (2019) 134 (Supplement_1): 4002.

https://doi.org/10.1182/blood-2019-126574

Published: 2019

Journal Articles

Phase 2 Study of Abbreviated 3 Cycles of Rituximab Plus CHOP (Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients with Completely Excised Stage I or II CD20+ Diffuse Large B-Cell Lymphoma (CISL 12-09)

Dok Hyun Yoon, Byeong Seok Sohn, PhD, Jung Yong Hong, Sung Yong Oh, MD, Won-Sik Lee, Sang Min Lee, Deok-Hwan Yang, Jooryung Huh, Cheolwon Suh

Blood (2016) 128 (22): 4193.

https://doi.org/10.1182/blood.V128.22.4193.4193

Published: 2016

Journal Articles

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

Sung-Yong Kim, MD, Seok-Goo Cho, Won-Sik Lee, MD, Suk-Woo Yang, MD, Sung Yong Oh, MD, Hee Bae Ahn, MD, Deok-Hwan Yang, Seong Kyu Park, Jee Ho Chang, MD, Hyo Jung Kim, MD PhD, Min Joung Lee, Jae Wook Yang

Blood (2016) 128 (22): 2981.

https://doi.org/10.1182/blood.V128.22.2981.2981

Published: 2016

Journal Articles

Phase II Trial of R-CVP Followed By Rituximab Maintenance Therapy for Patients with Advanced Stage Marginal Zone Lymphoma- Consortium for Improving Survival of Lymphoma (CISL) Study

Blood (2016) 128 (22): 1811.

https://doi.org/10.1182/blood.V128.22.1811.1811

Published: 2016

Journal Articles

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Kyoung Ha Kim, Lee Jae Hoon, Mark Lee, Kim Hoon-Gu, Young Rok Do, Yong Park, MD PhD, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Won Seog Kim, Sung-Kyu Park, MD, Jong-Ho Won, Jee Hyun Kong, Moo-Rim Park, MD, Je-Jung Lee, Jae-Yong Kwak, Hye Jin Kang, MD PhD, Yeung-Chul Mun

Blood (2016) 128 (22): 3466.

https://doi.org/10.1182/blood.V128.22.3466.3466

Published: 2016

Journal Articles

Clinical Outcomes in Patients with Diffuse Large B Cell Lymphoma with Partial Responses to First-Line R-CHOP Chemotherapy: Prognostic Value of Secondary IPI Scores and FDG-PET

Hyewon Lee, MD, Yu Ri Kim, Soo-Jeong Kim, MD, Yong Park, MD PhD, Hyeon-Seok Eom, Sung Yong Oh, MD, Hyo Jung Kim, Hye Jin Kang, Won-Sik Lee, Joon Ho Moon, MD, PhD, Young-Woong Won, MD PhD, Myung Hee Chang, Hye In Park, Jin Seok Kim, MD PhD

Blood (2016) 128 (22): 4205.

https://doi.org/10.1182/blood.V128.22.4205.4205

Published: 2016

Journal Articles

Clinical Usefulness of Inflammatory Factors Based Modified International Prognostic Index in Diffuse Large B Cell Lymphoma Treated with Rituximab Combined Chemotherapy

Cheolsu Kim, MD, Ho Sup Lee, MD PhD, Jae-Cheol Jo, MD PhD, Ho-Jin Shin, MD PhD, Sung Yong Oh, MD, Won Sik Lee, MD, Jee-yeong Jeong, PhD

Blood (2016) 128 (22): 4220.

https://doi.org/10.1182/blood.V128.22.4220.4220

Published: 2016

Journal Articles

The Efficacy of JAK2 Inhibitor in Heavily Pretreated Classical Hodgkin Lymphoma: A Prospective Pilot Study of Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Seok Jin Kim, MD PhD, Hye Jin Kang, MD PhD, Shin Dong-Yeop, MD PhD, Ho Sup Lee, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Dok Hyun Yoon, Jung Yong Hong, MD, Jee Hyun Kong, Kana Sakamoto, Young Hyeh Ko, MD, Kengo Takeuchi, MD PhD, Cheolwon Suh, Won Seog Kim

Blood (2016) 128 (22): 1820.

https://doi.org/10.1182/blood.V128.22.1820.1820

Published: 2016

Journal Articles

Herpesviridae Viral Infections Following Rituximab Combined Chemotherapy In Patients with Diffuse Large B Cell Lymphoma

Ho Sup Lee, MD, Lee Chun Park, MD, Seong Hoon Shin, MD, Byeong Jin Ye, MD, Moo-Kon Song, MD, Sung Yong Oh, MD, Sang Min Lee, MD, Won Sik Lee, MD, Yang Soo Kim, MD

Blood (2010) 116 (21): 1748.

https://doi.org/10.1182/blood.V116.21.1748.1748

Published: 2010

Journal Articles

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Byeong-Bae Park, MD, Jong Gwang Kim, MD,PhD, HyeonSeok Eom, MD,PhD, Hyo Jin Kim, MD,PhD, Hyuck Chan Kwon, MD,PhD, Sung Yong Oh, MD, Jung Hun Kang, MD, Suk Joong Oh, MD,PhD, Ho-Jin Shin, MD,PhD, Cheolwon Suh, MD,PhD, Jung Han Kim, MD, Ho Young Kim, MD, Sang Cheol Lee, MD, Kihyun Kim, MD,PhD, Chul W. Jung, MD,PhD, Won Seog Kim, MD,PhD

Blood (2006) 108 (11): 4670.

https://doi.org/10.1182/blood.V108.11.4670.4670

Published: 2006

Journal Articles

Prospective Clinical Study of Surgical Resection Followed by CHOP in Localized Intestinal Lymphoma.

Jeeyun Lee, MD, Won Seog Kim, MD, Sung Yong Oh, MD, Jung Mi Kwon, MD, Hyun Jung Kim, MD, Hyo-Rak Lee, MD, Byeong Bae Park, MD, Kihyun Kim, MD, Chul W. Jung, MD, Keunchil Park, MD

Blood (2005) 106 (11): 4743.

https://doi.org/10.1182/blood.V106.11.4743.4743

Published: 2005

Journal Articles

A Randomized Trial of Heparin Plus Anti-Thrombin III (ATIII) vs. Heparin Alone To Prevent VOD after HSCT.

Chul W. Jung, MD, Jeeyun Lee, MD, Byeong Bae Park, MD, Se H. Park, MD, Jung Han Kim, MD, Jung Mi Kwon, MD, Sung Yong Oh, MD, Hyun Jung Kim, MD, Hyorak Lee, MD, Kihyun Kim, MD, Jin Seok Ahn, MD, Won Seog Kim, MD, Keunchil Park, MD

Blood (2005) 106 (11): 1769.

https://doi.org/10.1182/blood.V106.11.1769.1769

Published: 2005

Journal Articles

Nongastric Marginal Zone B-Cell Lymphoma: Analysis of 247 Cases - Clinical Presentation and Treatment Outcomes of Nongastric Marginal Zone B-Cell Lymphoma.

Blood (2005) 106 (11): 1491.

https://doi.org/10.1182/blood.V106.11.1491.1491

Published: 2005

NARROW

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

Phase 2 Study of Abbreviated 3 Cycles of Rituximab Plus CHOP (Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients with Completely Excised Stage I or II CD20+ Diffuse Large B-Cell Lymphoma (CISL 12-09)

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

Phase II Trial of R-CVP Followed By Rituximab Maintenance Therapy for Patients with Advanced Stage Marginal Zone Lymphoma- Consortium for Improving Survival of Lymphoma (CISL) Study

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Clinical Outcomes in Patients with Diffuse Large B Cell Lymphoma with Partial Responses to First-Line R-CHOP Chemotherapy: Prognostic Value of Secondary IPI Scores and FDG-PET

Clinical Usefulness of Inflammatory Factors Based Modified International Prognostic Index in Diffuse Large B Cell Lymphoma Treated with Rituximab Combined Chemotherapy

The Efficacy of JAK2 Inhibitor in Heavily Pretreated Classical Hodgkin Lymphoma: A Prospective Pilot Study of Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Herpesviridae Viral Infections Following Rituximab Combined Chemotherapy In Patients with Diffuse Large B Cell Lymphoma

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Prospective Clinical Study of Surgical Resection Followed by CHOP in Localized Intestinal Lymphoma.

A Randomized Trial of Heparin Plus Anti-Thrombin III (ATIII) vs. Heparin Alone To Prevent VOD after HSCT.

Nongastric Marginal Zone B-Cell Lymphoma: Analysis of 247 Cases - Clinical Presentation and Treatment Outcomes of Nongastric Marginal Zone B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only